Yes
I do.
No
I don’t.
President Donald Trump’s administration is using federal authority to reshape healthcare policy, raising a larger debate over how much influence Washington should have over hospitals receiving federal money or operating under federal healthcare laws.
One recent example involves medical treatments for minors experiencing gender dysphoria. The Trump administration has moved to restrict federal Medicaid and Children’s Health Insurance Program funding for certain gender-transition treatments for minors.
The Justice Department has also reached agreements with major healthcare providers over these treatments. In September, Mount Sinai Health System agreed to stop providing specified gender-transition interventions to minors as part of an agreement resolving a federal investigation. The Justice Department said the investigation concerned potential violations of federal law. Mount Sinai denied the government’s allegations, and the settlement did not constitute a determination of liability.
Supporters of the administration’s approach argue that the federal government has both the authority and responsibility to establish rules surrounding federal healthcare dollars and enforce federal law. Critics argue that Washington risks interfering with decisions traditionally made by doctors, patients, parents, hospitals and state governments.
The controversy therefore raises a broader question extending beyond any single medical procedure: When hospitals participate in federally funded programs, how much authority should a presidential administration have to determine the policies they must follow?